funding · DK · 25 AUG 2026
Aarhus-based NorFalk has raised new capital to accelerate its path to market for the company's biobased chemistry.
NorFalk · —
Lead investor: Delphinus Venture Capital
Provenance
Sources
TechSavvy.media · 25 Aug 2026
Biobaseret kemi rykker tættere på markedet med ny investering
NorFalk har rejst kapital fra Delphinus Venture Capital og en række business angels. Det aarhusianske biotech-startup har nu passeret 5 millioner euro i samlet funding... Indlægget Biobaseret kemi…